Naltrexone
6
3
3
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
16.7%
1 terminated out of 6 trials
50.0%
-36.5% vs benchmark
17%
1 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia
RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response
Study for Naltrexone on the Abuse Potential of Methylphenidate